NO20081167L - Fluoriseringsframgangsmate - Google Patents

Fluoriseringsframgangsmate

Info

Publication number
NO20081167L
NO20081167L NO20081167A NO20081167A NO20081167L NO 20081167 L NO20081167 L NO 20081167L NO 20081167 A NO20081167 A NO 20081167A NO 20081167 A NO20081167 A NO 20081167A NO 20081167 L NO20081167 L NO 20081167L
Authority
NO
Norway
Prior art keywords
formula
compound
alkyl
precursors
fluoride
Prior art date
Application number
NO20081167A
Other languages
English (en)
Other versions
NO341560B1 (no
Inventor
Robert James Nairne
Anthony Eamon Storey
Clare Louise Jones
Denis Raymond Christophe Bouvet
Nicolas Lasbistes
Steven Michael Fairway
Lorenzo Williams
Alexander Mark Gibson
Farhad Karimi
Bengt Langstrom
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of NO20081167L publication Critical patent/NO20081167L/no
Publication of NO341560B1 publication Critical patent/NO341560B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
    • C07C209/74—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton by halogenation, hydrohalogenation, dehalogenation, or dehydrohalogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/45—Monoamines
    • C07C211/46—Aniline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/24—Stationary reactors without moving elements inside
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Oppfinnelsen angår en framgangsmåte for framstilling av en forbindelse av formel (I): der R1 er valgt blant C1-6-alkyl, C2-6-alkenyl, og C2-6-alkynyl, som omfatter: (i) reaksjon mellom fluorid, gjerne [18F]fluorid, og en tilsvarende forbindelse av formel (II): der R2 er valgt blant hydrogen, C1-10-alkyl, C1-10-halogenalkyl, C6-14-aryl, C6-14-arylalkyl, -(CH2CH2O)q-CH3 der q er et heltall fra 1 til 10, R1 er som definert for forbindelsen av formel (I), og R3 er en utgående gruppe. Visse nye forløpere av formel (II) og radiofarmasøytiske sett som inneholder slike forløpere er også omfattet av oppfinnelsen.
NO20081167A 2005-08-12 2008-03-05 Fluorineringsframgangsmåter, nye forbindelser, samt radiofarmasøytiske sett og kassetter NO341560B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0516564.2A GB0516564D0 (en) 2005-08-12 2005-08-12 Fluorination process
PCT/GB2006/003009 WO2007020400A1 (en) 2005-08-12 2006-08-11 Fluorination process of anilide derivatives and benzothiazole fluorinate derivatives as in vivo imaging agents

Publications (2)

Publication Number Publication Date
NO20081167L true NO20081167L (no) 2008-03-05
NO341560B1 NO341560B1 (no) 2017-12-04

Family

ID=35098197

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081167A NO341560B1 (no) 2005-08-12 2008-03-05 Fluorineringsframgangsmåter, nye forbindelser, samt radiofarmasøytiske sett og kassetter

Country Status (21)

Country Link
US (3) US8410312B2 (no)
EP (1) EP1915330B1 (no)
JP (2) JP5566605B2 (no)
KR (2) KR101409608B1 (no)
CN (2) CN101282920B (no)
AU (1) AU2006281216B2 (no)
BR (1) BRPI0614752B1 (no)
CA (1) CA2618448C (no)
DK (1) DK1915330T3 (no)
ES (1) ES2527864T3 (no)
GB (1) GB0516564D0 (no)
HK (1) HK1177463A1 (no)
IL (1) IL188933A0 (no)
MX (2) MX341173B (no)
NO (1) NO341560B1 (no)
NZ (1) NZ565333A (no)
PL (1) PL1915330T3 (no)
PT (1) PT1915330E (no)
RU (1) RU2419601C2 (no)
WO (1) WO2007020400A1 (no)
ZA (1) ZA200801860B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0516564D0 (en) * 2005-08-12 2005-09-21 Ge Healthcare Ltd Fluorination process
WO2008106442A1 (en) * 2007-02-27 2008-09-04 Ge Healthcare Limited Synthesis of [18f] fluoromethyl benzene using benzyl pentafluorobenzenesulfonate
DK2182988T3 (da) * 2007-08-30 2014-05-26 Ge Healthcare Ltd Radiofarmaceutisk præparat
EP2238074A2 (en) 2008-01-03 2010-10-13 GE Healthcare UK Limited Fluoride processing method
ES2540536T3 (es) 2008-09-23 2015-07-10 Wista Laboratories Ltd. Ligandos para moléculas tau agregadas
GB0921967D0 (en) * 2009-12-17 2010-02-03 Ge Healthcare Ltd Novel Aryloxyanilide Derivatives
GB201019303D0 (en) 2010-11-15 2010-12-29 Strom Hans E P Agents and methods for visualising analytes
CN103613589B (zh) * 2013-11-29 2016-03-30 江苏华益科技有限公司 一种用于神经退行性疾病领域的新型pet显像剂前体及标准品的合成方法
WO2016087653A1 (en) 2014-12-04 2016-06-09 Ge Healthcare Limited Method of removing acetaldehyde from radioactive pharmaceuticals
JP6485914B2 (ja) * 2015-10-28 2019-03-20 日本メジフィジックス株式会社 フルテメタモルの製造方法
JP6955347B2 (ja) 2017-02-28 2021-10-27 日本メジフィジックス株式会社 フルテメタモルの製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878206A (en) * 1973-06-06 1975-04-15 Morton Norwich Products Inc 9-(Substituted amino)imidazo{8 4,5-f{9 quinolines
FR2449677B1 (fr) 1979-02-26 1986-03-28 Fabre Sa Pierre Nouveaux derives de benzoyl-2 glycylanilides substitues, leur preparation et leur application en tant que medicaments anxiolytiques
FR2693781B1 (fr) * 1992-07-15 1994-10-28 Otis Elevator Co Dispositif de réglage de la tension d'un câble faisant boucle.
DE4402056A1 (de) 1994-01-25 1995-07-27 Basf Ag p-Phenylendiamin-Derivate und sie enthaltende fungizide Mittel
US7270800B2 (en) * 2000-08-24 2007-09-18 University Of Pittsburgh Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
GB0229686D0 (en) * 2002-12-20 2003-01-29 Amersham Plc Solid-phase fluorination of benzothiazoles
RU2440995C2 (ru) * 2003-03-14 2012-01-27 Юнивесити Оф Питсбэг Производные бензотиазола, фармацевтическая композиция, обладающая свойством связывать амилоид, и способ детекции отложений амилоида у млекопитающего
CA2438032C (en) 2003-03-14 2013-05-07 University Of Pittsburgh Benzothiazole derivative compounds, compositions and uses
PT1771208E (pt) * 2004-07-02 2013-09-24 Univ Pittsburgh Utilização de derivados de tioflavina radiorotulados em imagiologia amiloide para avaliar terapias anti-amiloide
GB0516564D0 (en) * 2005-08-12 2005-09-21 Ge Healthcare Ltd Fluorination process

Also Published As

Publication number Publication date
MX341173B (es) 2016-08-10
RU2419601C2 (ru) 2011-05-27
KR20130114279A (ko) 2013-10-16
US9468694B2 (en) 2016-10-18
KR101392538B1 (ko) 2014-05-07
JP2009507775A (ja) 2009-02-26
IL188933A0 (en) 2008-04-13
WO2007020400A1 (en) 2007-02-22
CN102731432A (zh) 2012-10-17
CA2618448A1 (en) 2007-02-22
US9126961B2 (en) 2015-09-08
NO341560B1 (no) 2017-12-04
JP5566605B2 (ja) 2014-08-06
US20130225829A1 (en) 2013-08-29
HK1177463A1 (zh) 2013-08-23
CN101282920B (zh) 2014-06-04
MX2008002068A (es) 2008-04-16
US20150328344A1 (en) 2015-11-19
BRPI0614752B1 (pt) 2024-01-09
US20100234611A1 (en) 2010-09-16
NZ565333A (en) 2011-07-29
KR101409608B1 (ko) 2014-06-18
KR20080035618A (ko) 2008-04-23
JP2014028837A (ja) 2014-02-13
BRPI0614752A2 (pt) 2012-12-04
EP1915330A1 (en) 2008-04-30
CN102731432B (zh) 2015-10-21
RU2008103989A (ru) 2009-09-20
PT1915330E (pt) 2015-01-16
AU2006281216A1 (en) 2007-02-22
ES2527864T3 (es) 2015-01-30
DK1915330T3 (en) 2015-01-19
ZA200801860B (en) 2008-12-31
CN101282920A (zh) 2008-10-08
CA2618448C (en) 2014-05-06
US8410312B2 (en) 2013-04-02
PL1915330T3 (pl) 2015-03-31
AU2006281216B2 (en) 2012-01-19
GB0516564D0 (en) 2005-09-21
EP1915330B1 (en) 2014-12-10

Similar Documents

Publication Publication Date Title
NO20081167L (no) Fluoriseringsframgangsmate
TW200503724A (en) Novel pharmaceuticals
MX2009013591A (es) Proceso para la preparacion de pirazoles.
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
MX2008010481A (es) Compuestos que tienen afinado para el receptor f-ht6.
WO2006135641A3 (en) PROCESS FOR THE SYNTHESIS OF 5- (METHYL-lH-IMIDAZOL-l-YL) -3- (TRI FLUOROME TH YL) -BENZENEAMINE
MX2009004343A (es) Compuestos organicos.
WO2005070884A3 (en) Heterocyclic compounds useful as growth hormone secretagogues
NO20071242L (no) Triazolpyridinylsulfanylderivater som P38-MAP-kinaseinhibitorer
HK1125358A1 (en) Substituted cyclohexylmethyl derivatives
NO20082116L (no) Kjemisk fremgangsmate for fremstilling av en amido-fenoksybenzosyreforbindelse
NO20071012L (no) Fremgangsmate for fremstilling av D-erytro-2,2-difluor-2-deoksy-1-oksoribosederivat
NO20091575L (no) Hoyenhets massetilberedning av stannsoporfin
SG153856A1 (en) Chemical process
NO20071253L (no) Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer.
WO2008103367A3 (en) Method for assembling high-purity chemical libraries, proapoptotic compounds discovered by same
NO20076161L (no) Fremgangsmater for fremstilling av 4-bifenylazetidin-2-oner
GB0327323D0 (en) Novel pharmaceuticals
GB0215392D0 (en) Chemical compounds
MX2010001512A (es) Nuevo procedimiento de preparacion.
NO20052197L (no) Fremgangsmate for fremstilling av pyrazol
IN2012DN02871A (no)
NO20092210L (no) Salter av dihydroksyantrakinon-karboksylsyrer og deres terapeutiske anvendelse
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
NO20070776L (no) Forbedret prosess for fremstilling av mirtazapin

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA